Medcaptain Medical Technology Co., Ltd. (MEDCAPTAIN) filed its Monthly Return for Equity Issuer for the period ended 31 October 2026, confirming stability in its share capital structure and compliance with Hong Kong’s minimum public-float requirements.

Authorised / Registered Capital • Registered share capital remained unchanged at RMB 538.63 million, comprising 479.22 million H-shares and 59.41 million domestic unlisted shares, each with a par value of RMB 1.00.

Issued Shares and Public Float • Total issued H-shares stood at 479.22 million, with zero treasury shares outstanding. • Domestic unlisted shares totalled 59.41 million, also unchanged. • The company affirmed that its public float exceeds the 15 % minimum threshold required by the Hong Kong Stock Exchange.

Share-Based Incentives • Under the Pre-IPO Share Option Scheme adopted on 16 December 2024, 470,000 options were cancelled during the month. • Outstanding options declined to 23.40 million, all carrying an exercise price of RMB 4.00 per share. • No new shares were issued, and no funds were raised via option exercises in October.

Capital Movements • MEDCAPTAIN reported no issuance or cancellation of shares, no share repurchases, and no activity involving warrants, convertibles, or other equity-linked instruments.

Governance and Compliance • The filing was signed by Joint Company Secretary Yan Renzhong, who confirmed adherence to all relevant listing rules and regulatory requirements.

With no alterations to its issued share capital and continued compliance with public-float rules, MEDCAPTAIN’s equity structure remained steady through October 2026.